Facebook buys AOL patents from Microsoft

Facebook buys AOL patents from Microsoft

Facebook has confirmed that it has agreed to purchase a portion of AOL patents from Microsoft, a move that is expected to strengthen the social-networking firm's position against Yahoo in the intellectual property battle.

The world's biggest social network will purchase 650 of the AOL patents and patent applications in a $550 million deal. Microsoft will retain 275 AOL patents. The software giant had acquired the patents from AOL auction.

The software giant will also keep hold of licenses for three hundred additional patents that have been retained by AOL.

Facebook and Microsoft have also agreed to provide access to each other's holdings through licenses.

It is worth-mentioning here that Microsoft owns roughly 1.6 per cent stake in Facebook, which claims to have around 900 million active monthly users.

Describing the deal as "important", Facebook's general counsel Ted Ullyot said, "This is another significant step in our ongoing process of building an intellectual property portfolio to protect Facebook's interests over the long term."

The $550 million acquisition marks Facebook's second-largest transaction, after the $1 billion purchase of Instagram.


Tagged with

Miscellaneous

Tata Sons cancels stake sale in TTML

Tata Sons cancels stake sale in TTML

Tata Sons Ltd on Friday confirmed that its decision to cancel its offer for sale (OFS) of shares in its subsidiary Tata Teleservices (Maharashtra) Ltd.

The OFS was announced on Wednesday, when Tata Sons said that it would sell a total of 51,623,679 shares, or 2.72 per cent of the equity capital of the Tata Teleservices (Maharashtra) Ltd, on May 17.

But, the company yesterday confirmed that it had cancelled the sale. In a filing to the Bombay Stock Exchange (BSE), the company said, "Tata Sons Limited has now informed BSE that they have decided to cancel the sale in full."

Prices of several life-saving drugs to drop by up to 80%

Prices of several life-saving drugs to drop by up to 80%

The prices of several life-saving medicines will soon fall by up to 80 per cent in India, thanks to the government's new drug price control order.

Issued by the union government, the long-pending drug price control order has paved the way for the implementation of pharmaceutical pricing control policy across the country. It is expected to reduce the prices of drugs on an average by 20-25 per cent, and some cancer drugs by up to 80 per cent.